Jennison Associates’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.9M Buy
154,465
+78,027
+102% +$25.3M 0.03% 232
2025
Q4
$23.2M Buy
76,438
+2,840
+4% +$930K 0.01% 318
2025
Q3
$25.1M Buy
+73,598
New +$22.3M 0.01% 310
2021
Q3
Sell
-27,230
Closed -$9.35M 740
2021
Q2
$9.35M Buy
27,230
+7,131
+35% +$2.36M 0.01% 466
2021
Q1
$7M Buy
20,099
+12,708
+172% +$4.21M 0.01% 448
2020
Q4
$1.91M Buy
7,391
+2,041
+38% +$562K ﹤0.01% 522
2020
Q3
$1.53M Buy
5,350
+492
+10% +$116K ﹤0.01% 514
2020
Q2
$915K Buy
4,858
+2,617
+117% +$426K ﹤0.01% 531
2020
Q1
$276K Buy
2,241
+35
+2% +$5.47K ﹤0.01% 610
2019
Q4
$366K Buy
+2,206
New +$367K ﹤0.01% 610
2019
Q2
Sell
-4,513
Closed -$596K 680
2019
Q1
$596K Hold
4,513
﹤0.01% 606
2018
Q4
$633K Buy
4,513
+86
+2% +$11.4K ﹤0.01% 576
2018
Q3
$762K Buy
4,427
+43
+1% +$7.23K ﹤0.01% 576
2018
Q2
$674K Buy
+4,384
New +$782K ﹤0.01% 594

Other funds holding ONC